Skip to main content
Journal of the National Medical Association logoLink to Journal of the National Medical Association
editorial
. 2006 Nov;98(11):1860–1861.

Higher Prevalence of Monoclonal Gammopathy of Undetermined Significance In African Americans than Whites—The Unknown Role of Underlying HIV Infection

Panagiotis A Konstantinopoulos, Liron Pantanowitz, Bruce J Dezube
PMCID: PMC2569800  PMID: 17128699

Abstract

The age-adjusted prevalence rate of monoclonal gammopathy of undetermined significance (MGUS) is three-fold higher in African Americans than whites. Similarly, there is a higher preponderance of multiple myeloma (MM) in African-American patients. Since the risk of progression of MGUS to MM is equal in both races, identification of exogenous and genetic risk factors of MGUS [such as genetic pre-disposition; diet; and chronic antigenic exposure related to sexually transmitted diseases, including human immunodeficiency virus (HIV) infection] is essential for unraveling the etiology of the racial disparity for MM. HIV infection, a well-documented risk factor for MGUS, is more frequent in African-American patients. Future epidemiologic studies dealing with plasma cell disorders should carefully examine the relationship between race, HIV infection status, prevalence of MGUS and its ultimate progression to MM.

Keywords: monoclonal gammopathy of unknown significance, multiple myeloma, HIV/AIDS, racial disparity, plasma cell disorders

Full text

PDF
1860

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Carraway Hetty, Ambinder Richard F. Plasma cell dyscrasia, Hodgkin lymphoma, HIV, and Kaposi sarcoma-associated herpesvirus. Curr Opin Oncol. 2002 Sep;14(5):543–545. doi: 10.1097/00001622-200209000-00012. [DOI] [PubMed] [Google Scholar]
  2. Dezube Bruce J., Aboulafia David M., Pantanowitz Liron. Plasma cell disorders in HIV-infected patients: from benign gammopathy to multiple myeloma. AIDS Read. 2004 Jul;14(7):372-4, 377-9. [PubMed] [Google Scholar]
  3. Fiorino A. S., Atac B. Paraproteinemia, plasmacytoma, myeloma and HIV infection. Leukemia. 1997 Dec;11(12):2150–2156. doi: 10.1038/sj.leu.2400875. [DOI] [PubMed] [Google Scholar]
  4. Goedert J. J., Coté T. R., Virgo P., Scoppa S. M., Kingma D. W., Gail M. H., Jaffe E. S., Biggar R. J. Spectrum of AIDS-associated malignant disorders. Lancet. 1998 Jun 20;351(9119):1833–1839. doi: 10.1016/s0140-6736(97)09028-4. [DOI] [PubMed] [Google Scholar]
  5. Jin D. K., Nowakowski M., Kramer M., Essex D. W. Hyperviscosity syndrome secondary to a myeloma-associated IgG(1)kappa paraprotein strongly reactive against the HIV-1 p24 gag antigen. Am J Hematol. 2000 Jul;64(3):210–213. doi: 10.1002/1096-8652(200007)64:3<210::aid-ajh13>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  6. Landgren Ola, Gridley Gloria, Turesson Ingemar, Caporaso Neil E., Goldin Lynn R., Baris Dalsu, Fears Thomas R., Hoover Robert N., Linet Martha S. Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States. Blood. 2005 Oct 6;107(3):904–906. doi: 10.1182/blood-2005-08-3449. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of the National Medical Association are provided here courtesy of National Medical Association

RESOURCES